Search results - 3 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
2022 onwards in most participating countries except for Belgium and Portugal, where it started earlier in spring 2022 in those aged ≥80 followed by 50–79year olds in autumn 2022. In these two countries, ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
B Human immune response Impact INFORMATION Institute IS IT Laboratories LEVEL marketing means mechanism medicinal product ON organization physical present PRESENTATION protection public public health ...
Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis.
a putative 26-aa signal sequence, was isolated, and sequence analysis indicated that the protein was 98% identical with the M. tuberculosis Lppx protein and that it contained a sequence 94% identical with the ...